243 related articles for article (PubMed ID: 28878084)
21. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6.
Wan X; Wang H; Nicholas J
J Virol; 1999 Oct; 73(10):8268-78. PubMed ID: 10482577
[TBL] [Abstract][Full Text] [Related]
22. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
[TBL] [Abstract][Full Text] [Related]
24. Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display.
Kovaleva M; Bussmeyer I; Rabe B; Grötzinger J; Sudarman E; Eichler J; Conrad U; Rose-John S; Scheller J
J Virol; 2006 Sep; 80(17):8510-20. PubMed ID: 16912301
[TBL] [Abstract][Full Text] [Related]
25. Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia.
Nicholas J
Front Biosci; 2007 Jan; 12():265-81. PubMed ID: 17127298
[TBL] [Abstract][Full Text] [Related]
26. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
27. Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6.
Chen D; Nicholas J
J Virol; 2006 Oct; 80(19):9811-21. PubMed ID: 16973585
[TBL] [Abstract][Full Text] [Related]
28. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
[TBL] [Abstract][Full Text] [Related]
29. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
30. UDP-glucose:glycoprotein glucosyltransferase (UGGT1) promotes substrate solubility in the endoplasmic reticulum.
Ferris SP; Jaber NS; Molinari M; Arvan P; Kaufman RJ
Mol Biol Cell; 2013 Sep; 24(17):2597-608. PubMed ID: 23864712
[TBL] [Abstract][Full Text] [Related]
31. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
32. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.
Morris VA; Punjabi AS; Wells RC; Wittkopp CJ; Vart R; Lagunoff M
Virology; 2012 Jul; 428(2):112-20. PubMed ID: 22521915
[TBL] [Abstract][Full Text] [Related]
33. Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.
Aoki Y; Narazaki M; Kishimoto T; Tosato G
Blood; 2001 Nov; 98(10):3042-9. PubMed ID: 11698289
[TBL] [Abstract][Full Text] [Related]
34. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization.
Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S
Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991
[TBL] [Abstract][Full Text] [Related]
35. Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6.
Hu F; Nicholas J
J Virol; 2006 Nov; 80(21):10874-8. PubMed ID: 16956953
[TBL] [Abstract][Full Text] [Related]
36. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
37. Identification of amino acid residues of gp130 signal transducer and gp80 alpha receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6.
Li H; Nicholas J
J Virol; 2002 Jun; 76(11):5627-36. PubMed ID: 11991991
[TBL] [Abstract][Full Text] [Related]
38. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Staskus KA; Sun R; Miller G; Racz P; Jaslowski A; Metroka C; Brett-Smith H; Haase AT
J Virol; 1999 May; 73(5):4181-7. PubMed ID: 10196314
[TBL] [Abstract][Full Text] [Related]
39. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells.
Klouche M; Brockmeyer N; Knabbe C; Rose-John S
AIDS; 2002 May; 16(8):F9-18. PubMed ID: 12004288
[TBL] [Abstract][Full Text] [Related]
40. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
